在心力衰竭患者中,甘油三指数和相关参数的值
Yunteng Fang1,2, Jiayi Shen2, Lingchun Lyu1,2
1Lishui Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Frontiers in cardiovascular medicine
|August 2, 2024
概括
甘油三糖 (TyG) 指数是关键的胰岛素抵抗标志物,与心血管疾病 (CVD) 风险相关. 本综述探讨了它在心力衰竭 (HF) 中的作用以及SGLT2抑制剂的影响.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 甘油三糖指数 (TyG) 是一种已验证的胰岛素耐药性的生物标志物,超过了传统的方法,如HOMA-IR.
- 新兴证据强烈地将TyG指数与心血管疾病 (CVD) 的预后和死亡率联系在一起,包括动脉样硬化,心力衰竭 (HF) 和高血压.
- 对于心力衰竭患者的TyG指数的临床实用性,特别是那些接受-葡萄糖共运输体2抑制剂 (SGLT2is) 治疗的患者,仍未得到充分研究.
研究的目的:
- 系统地审查TyG指数和心血管疾病相关参数的预后值,特别关注心力衰竭.
- 评估SGLT2抑制剂和GLP-1受体对抗剂在治疗心力衰竭患者中的作用.
- 在心血管健康的背景下阐明"肥胖悖论"的潜在机制.
主要方法:
- 文献综述和现有研究的综合.
- 对TyG指数与心血管结果之间的关联进行分析.
- 检查SGLT2is和GLP-1受体对抗剂在心力衰竭中的治疗作用.
主要成果:
- 泰格指数是心血管事件和死亡率的重要预测指标.
- SGLT2抑制剂和GLP-1受体对抗剂在改善心力衰竭患者的治疗结果方面显示出有前途.
- "肥胖悖论"的机制正在与代谢和心血管健康有关的研究中.
结论:
- 泰格指数是一个有价值的,非侵入性的生物标志物,用于评估心血管风险,特别是心力衰竭.
- 需要进一步的研究,以充分理解TyG指数,SGLT2抑制剂和心力衰竭管理之间的相互作用.
- 了解"肥胖悖论"可能为心血管疾病提供新的治疗策略.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
143
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
143
Dipeptidyl Peptidase 4 Inhibitors
180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180
Hypoglycemia and Glucagon
229
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
229
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69


